Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B2c3f06fad6b27a6766aaeda4e3640b24> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B2c3f06fad6b27a6766aaeda4e3640b24 NCIT_P378 "NCI" @default.
- B2c3f06fad6b27a6766aaeda4e3640b24 type Axiom @default.
- B2c3f06fad6b27a6766aaeda4e3640b24 annotatedProperty IAO_0000115 @default.
- B2c3f06fad6b27a6766aaeda4e3640b24 annotatedSource NCIT_C1144 @default.
- B2c3f06fad6b27a6766aaeda4e3640b24 annotatedTarget "The acetate salt form of nafarelin, a modified synthetic porcine luteinizing hormone (LH)-releasing hormone peptide analog, with gonadotropin-releasing hormone (GnRH) agonist activity. Upon nasal inhalation, nafarelin acetate binds to the GnRH receptor. This initially results in the release of the gonadotropins, follicle-stimulating hormone (FSH) and LH, from the pituitary gland; however, prolonged stimulation of the GnRH receptor desensitizes the receptor, which leads to decreased secretion of FSH and LH. In females, the inhibition of gonadotropin secretion causes hypogonadotropic hypogonadism leading to decreased production of estrogen and progesterone and anovulation. In males, the inhibition of LH secretion prevents the production and release of testosterone from Leydig cells in the testes and causes a significant decline in testosterone production that is near the levels seen following castration." @default.